Synopsis of recent research by authors named "So-El Jeon"
- So-El Jeon's recent research primarily focuses on the molecular mechanisms and potential therapeutic targets in colorectal cancer (CRC), exploring how various proteins and genes influence cancer aggressiveness and stemness.
- Key findings include the role of SEC22B in enhancing CRC aggressiveness and autophagic flux, the utility of machine learning for improving survival prediction models in colon cancer patients, and the involvement of DCLK1 and dysadherin in promoting aggressive cancer phenotypes through specific signaling pathways.
- The studies highlight the identification of genomic and proteomic biomarkers, offering insights into treatment strategies and the need for targeted therapies to address challenges like metastasis and cancer recurrence in CRC patients.
